For instance, engineered DEXs with hepatocellular carcinoma (HCC)-targeting peptide P47, the immunoadjuvant high-mobility group nucleosome-binding protein 1 (HMGN1), and an α-fetoprotein epitope. The gene discussed is HMGN5; the disease is hepatocellular carcinoma.